Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-06-18
DOI
https://doi.org/10.1016/j.eclinm.2025.103309
Citations
8
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
12.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

Nerea Ancizar, Xavier González, Antonio Llombart‐Cussac, María Gión et al.
8 citations
EClinicalMedicine
Advanced Breast Cancer Therapies
12.15
article

Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

Nerea Ancizar, Xavier González, Antonio Llombart‐Cussac, María Gión, Isabel Blancas, Sabela Recalde, Manuel Ruíz‐Borrego, Javier Cortés, Elena López-Miranda, Alejandro Martínez‐Bueno, Miguel Sampayo-Cordero, José Antonio López‐Guerrero, Serafin M. Morales, Cristina Reboredo Rendo, Patricia Cortez, J. M. Perez-Garcia, Salvador Blanch, Eileen Shimizu, Zuzanna Piwowarska
article en
8 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 85
Universidad de Granada (ES), Universidad Cardenal Herrera CEU (ES), Hospital Universitari Arnau de Vilanova (ES), Hospital Universitario de Torrejón (ES), Instituto Oncológico Dr. Rosell (ES), MedSIR (Spain) (ES), Fundación Instituto Valenciano de Oncología (ES), Institut Català d'Oncologia (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Arnau de Vilanova (ES), Hospital General de Catalunya (ES), Hospital de Sant Joan Despí Moisès Broggi (ES), Complexo Hospitalario Universitario A Coruña (ES), Hospital Ruber Internacional (ES), Hospital Universitario Virgen del Rocío (ES), International Breast Cancer Study Group (CH), Hospital Universitario Ramón y Cajal (ES), Universidad Europea de Madrid (ES)
Gilead Sciences, American Society of Clinical Oncology
Good health and well-being
Openalex Percentile: Top 1%
Advanced Breast Cancer Therapies
12.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.